ABEQ Overview

Fourth Quarter Financial Performance: Medtronic reported fourth-quarter 2025 sales of $8.93 billion, exceeding expectations, with adjusted EPS of $1.62 and a year-over-year revenue increase of 3.9%. The cardiovascular segment saw significant growth, while diabetes revenue rose by 10.4%.

Business Separation Announcement: Medtronic plans to separate its Diabetes business into a standalone company within 18 months, aiming for improved margins and focused growth in high-margin markets, alongside an increase in cash dividends and adjusted EPS.

Unilever's Strategic Shift: Unilever PLC is exploring the sale of smaller food brands in the Netherlands and other parts of Europe to streamline its portfolio and focus on key power brands, aiming for improved profitability and long-term growth under CEO Hein Schumacher.

Legal Tensions with Ben & Jerry's: The company's strategic changes come amid a lawsuit from Ben & Jerry’s, which accuses Unilever of suppressing its support for Palestinian refugees, highlighting ongoing conflicts between the two entities.

Expansion of Partnership: Accenture and Unilever are expanding their strategic partnership to enhance digital infrastructure and leverage generative AI for improved efficiency and productivity across global operations.

Implementation of GenWizard: Unilever will utilize Accenture's GenWizard platform, which includes over 350 patents, to accelerate technology development and achieve operational efficiencies, building on previous successful AI initiatives.